13F Holdings
中文EN

GWLL GOLDENWELL BIOTECH, INC.

Food and Kindred Products · OTC · SEC CIK 1800373 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-94.1%
TTM net income YoY-12.4%
TTM EPS YoY—
Revenue 3-yr CAGR-79.9%
Net income 3-yr CAGR—

Margins

Gross margin50.4%
Operating margin-88,556.1%
Net margin-94,542.4%
FCF margin—
EBITDA margin—

Returns

ROE-710.0%
ROA-58.1%
ROIC (approx.)-125.7%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets121.1%
Debt / equity—
Current ratio—
Interest coverage-14.65x

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-6.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$55$139$1,836$47,800$15,967
Cost of revenue$43$75$1,170$22,614$7,579
Gross profit$12$64$666$25,186$8,388
SG&A expense$113,338$123,162$116,492$1.01M$126,655
Operating income-$113,326-$123,098-$115,826-$985,105-$118,267
Interest expense$8,400$8,400$1,535—$0
Pretax income—-$131,498-$117,361—-$118,267
Income tax$0$0$0$0$0
Net income-$296,471-$131,498-$117,361-$985,097-$116,981
EPS (basic)————0.00
EPS (diluted)0.000.000.00—0.00
Weighted avg. shares (diluted)99.00M99.00M99.00M—91.32M
Banking
Noninterest expense—$8,400$1,535——
Balance sheet
Cash & equivalents$26,775$49,404$53,231$45,996$213,556
Receivables———$0$0
Inventory$174,745$174,788$174,863$176,058$198,671
Total assets$36,120$224,192$228,094$248,400$460,979
Current liabilities$101,860$1,860——$159,266
Long-term debt—$173,985$46,335——
Total debt—$173,985$46,335——
Total liabilities$424,833$271,433$143,837$46,782$159,266
Shareholders' equity-$343,713-$47,241$84,257$201,618$301,713
Net debt—$124,581-$6,896——
Shares outstanding99.00M99.00M99.00M99.00M91.50M
Cash flow statement
Operating cash flow-$22,629-$123,077-$113,153-$1.07M-$205,138
Financing cash flow$0$119,250$120,388$905,000$170,125

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.